FORESITE CAPITAL MANAGEMENT IV, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | PHVS | 4.78M | $132.61M |
 | ALEC | 3.89M | $6.06M |
 | RLAY | 1.00M | $8.46M |
 | LYEL | 800K | $24.64M |
 | MAZE | 523K | $21.65M |
 | CYTK | 458K | $29.12M |
 | XENE | 160K | $7.17M |
Pharvaris N.V.
PHVS
Shares Held
4.78M
Value
$132.61M
Alector, Inc.
ALEC
Shares Held
3.89M
Value
$6.06M
Relay Therapeutics, Inc.
RLAY
Shares Held
1.00M
Value
$8.46M
Lyell Immunopharma, Inc.
LYEL
Shares Held
800K
Value
$24.64M
Maze Therapeutics, Inc.
MAZE
Shares Held
523K
Value
$21.65M
Cytokinetics, Incorporated
CYTK
Shares Held
458K
Value
$29.12M
Xenon Pharmaceuticals Inc.
XENE
Shares Held
160K
Value
$7.17M